Journal of the American Medical Association最新文献

筛选
英文 中文
Beyond the AI Alarm: How ARPA-H Is Rethinking Innovation in Health Care. 超越人工智能警报:ARPA-H如何重新思考医疗保健创新。
IF 55
Journal of the American Medical Association Pub Date : 2026-10-20 DOI: 10.1001/jama.2026.15949
Yulin Hswen
{"title":"Beyond the AI Alarm: How ARPA-H Is Rethinking Innovation in Health Care.","authors":"Yulin Hswen","doi":"10.1001/jama.2026.15949","DOIUrl":"10.1001/jama.2026.15949","url":null,"abstract":"","PeriodicalId":17196,"journal":{"name":"Journal of the American Medical Association","volume":" ","pages":"e2615949"},"PeriodicalIF":55.0,"publicationDate":"2026-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149039504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Illicit Injectable Peptides-Reply. 非法注射肽-回复。
IF 55
Journal of the American Medical Association Pub Date : 2026-10-19 DOI: 10.1001/jama.2026.17242
Timothy Piatkowski, Kyle T Ganson, Jason M Nagata
{"title":"Illicit Injectable Peptides-Reply.","authors":"Timothy Piatkowski, Kyle T Ganson, Jason M Nagata","doi":"10.1001/jama.2026.17242","DOIUrl":"https://doi.org/10.1001/jama.2026.17242","url":null,"abstract":"","PeriodicalId":17196,"journal":{"name":"Journal of the American Medical Association","volume":" ","pages":""},"PeriodicalIF":55.0,"publicationDate":"2026-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149224302","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Illicit Injectable Peptides. 非法注射肽。
IF 55
Journal of the American Medical Association Pub Date : 2026-10-19 DOI: 10.1001/jama.2026.17239
Carolina Castro Porto Silva Janovsky
{"title":"Illicit Injectable Peptides.","authors":"Carolina Castro Porto Silva Janovsky","doi":"10.1001/jama.2026.17239","DOIUrl":"https://doi.org/10.1001/jama.2026.17239","url":null,"abstract":"","PeriodicalId":17196,"journal":{"name":"Journal of the American Medical Association","volume":" ","pages":""},"PeriodicalIF":55.0,"publicationDate":"2026-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149224247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Individualized Cardiac Index-Guided Hemodynamic Therapy in High-Risk Patients Undergoing Elective Major Abdominal Surgery: The PELICAN Randomized Clinical Trial. 个体化心脏指数引导血流动力学治疗高危患者择期腹部大手术:PELICAN随机临床试验。
IF 55
Journal of the American Medical Association Pub Date : 2026-10-19 DOI: 10.1001/jama.2026.18574
Bernd Saugel, Agnes S Meidert, Christian S Meyhoff, Rune Sort, Eske K Aasvang, Alina Bergholz, Abdelkader Serir, Eike Schwartze, Kristen K Thomsen, Christian Zöllner, Stephan Berthold, Melanie Borrmann, Joseph Esser, Anja Laska, Patrick Scheiermann, Nicolai Bang Foss, Jonathan Winther Olsen, Line Malmer Madsen, Anders H Welling, Christine Gaik, Sebastian Roth, Julian Schröder, Marc Vives, Adam Klimovic, Michael Eichlseder, Sebastian Goldmann, Thomas Renné, Henrike Hedrich, Eik Vettorazzi, Antonia Zapf, Karim Kouz, Moritz Flick
{"title":"Individualized Cardiac Index-Guided Hemodynamic Therapy in High-Risk Patients Undergoing Elective Major Abdominal Surgery: The PELICAN Randomized Clinical Trial.","authors":"Bernd Saugel, Agnes S Meidert, Christian S Meyhoff, Rune Sort, Eske K Aasvang, Alina Bergholz, Abdelkader Serir, Eike Schwartze, Kristen K Thomsen, Christian Zöllner, Stephan Berthold, Melanie Borrmann, Joseph Esser, Anja Laska, Patrick Scheiermann, Nicolai Bang Foss, Jonathan Winther Olsen, Line Malmer Madsen, Anders H Welling, Christine Gaik, Sebastian Roth, Julian Schröder, Marc Vives, Adam Klimovic, Michael Eichlseder, Sebastian Goldmann, Thomas Renné, Henrike Hedrich, Eik Vettorazzi, Antonia Zapf, Karim Kouz, Moritz Flick","doi":"10.1001/jama.2026.18574","DOIUrl":"https://doi.org/10.1001/jama.2026.18574","url":null,"abstract":"<p><strong>Importance: </strong>It remains unclear if intraoperative hemodynamic therapy should be guided by cardiac index.</p><p><strong>Objective: </strong>To evaluate whether individualized cardiac index-guided hemodynamic therapy vs routine hemodynamic therapy improves outcomes in high-risk patients undergoing elective major abdominal surgery.</p><p><strong>Design, setting, and participants: </strong>This multicenter, single-blind, superiority randomized clinical trial enrolled high-risk patients undergoing elective major abdominal surgery between October 8, 2023, and October 25, 2025, at 12 university medical centers in Austria, the Czech Republic, Denmark, Germany, and Spain. The date of last follow-up was January 15, 2026.</p><p><strong>Interventions: </strong>Patients were randomized to individualized cardiac index-guided hemodynamic therapy targeting the patient's preoperative resting cardiac index vs routine hemodynamic therapy (with blinded cardiac index monitoring).</p><p><strong>Main outcomes and measures: </strong>The primary outcome was a composite of acute kidney injury, acute myocardial injury, severe infectious complications, nonfatal cardiac arrest, or death within the first 7 postoperative days. Secondary outcomes included the individual components of the primary outcome within the first 7 postoperative days.</p><p><strong>Results: </strong>Of the 1128 patients enrolled, 1111 were randomized and 1095 were included in the primary analysis (median age, 67 years [IQR, 59-74 years]; 49.4% were female). The primary outcome occurred in 243 of 549 patients (44.3%) in the individualized cardiac index-guided hemodynamic therapy group vs 256 of 546 patients (46.9%) in the routine hemodynamic therapy group (relative risk, 0.94 [95.1% CI, 0.83-1.08]; P = .38). There were no between-group differences for the incidence of the individual components of the primary outcome within the first 7 postoperative days.</p><p><strong>Conclusions and relevance: </strong>Among high-risk patients undergoing elective major abdominal surgery, individualized cardiac index-guided hemodynamic therapy targeting the patient's preoperative resting cardiac index did not reduce the incidence of a composite outcome of acute kidney injury, acute myocardial injury, severe infectious complications, nonfatal cardiac arrest, or death within the first 7 postoperative days compared with routine hemodynamic therapy.</p><p><strong>Trial registration: </strong>ClinicalTrials.gov Identifier: NCT05648279.</p>","PeriodicalId":17196,"journal":{"name":"Journal of the American Medical Association","volume":" ","pages":""},"PeriodicalIF":55.0,"publicationDate":"2026-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149224295","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Individualized Cardiac Index-Guided Hemodynamic Therapy in High-Risk Patients Undergoing Elective Major Abdominal Surgery: Research Summary. 择期腹部大手术高危患者个体化心脏指数引导血流动力学治疗:研究综述。
IF 55
Journal of the American Medical Association Pub Date : 2026-10-19 DOI: 10.1001/jama.2026.18706
{"title":"Individualized Cardiac Index-Guided Hemodynamic Therapy in High-Risk Patients Undergoing Elective Major Abdominal Surgery: Research Summary.","authors":"","doi":"10.1001/jama.2026.18706","DOIUrl":"https://doi.org/10.1001/jama.2026.18706","url":null,"abstract":"","PeriodicalId":17196,"journal":{"name":"Journal of the American Medical Association","volume":" ","pages":"e2618706"},"PeriodicalIF":55.0,"publicationDate":"2026-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149224275","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Incorrect Affiliation. 不正确的关系。
IF 55
Journal of the American Medical Association Pub Date : 2026-10-19 DOI: 10.1001/jama.2026.22423
{"title":"Incorrect Affiliation.","authors":"","doi":"10.1001/jama.2026.22423","DOIUrl":"https://doi.org/10.1001/jama.2026.22423","url":null,"abstract":"","PeriodicalId":17196,"journal":{"name":"Journal of the American Medical Association","volume":" ","pages":""},"PeriodicalIF":55.0,"publicationDate":"2026-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149224309","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment Discontinuation of Blood Pressure-Lowering Drugs. 治疗:停用降压药。
IF 55
Journal of the American Medical Association Pub Date : 2026-10-15 DOI: 10.1001/jama.2026.16617
Wentao Wu, Shuohao Wang, Xia Gao
{"title":"Treatment Discontinuation of Blood Pressure-Lowering Drugs.","authors":"Wentao Wu, Shuohao Wang, Xia Gao","doi":"10.1001/jama.2026.16617","DOIUrl":"https://doi.org/10.1001/jama.2026.16617","url":null,"abstract":"","PeriodicalId":17196,"journal":{"name":"Journal of the American Medical Association","volume":" ","pages":""},"PeriodicalIF":55.0,"publicationDate":"2026-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149194817","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment Discontinuation of Blood Pressure-Lowering Drugs-Reply. 停药降压药的疗效。
IF 55
Journal of the American Medical Association Pub Date : 2026-10-15 DOI: 10.1001/jama.2026.16620
Nelson Wang, Abdul Salam, Anthony Rodgers
{"title":"Treatment Discontinuation of Blood Pressure-Lowering Drugs-Reply.","authors":"Nelson Wang, Abdul Salam, Anthony Rodgers","doi":"10.1001/jama.2026.16620","DOIUrl":"https://doi.org/10.1001/jama.2026.16620","url":null,"abstract":"","PeriodicalId":17196,"journal":{"name":"Journal of the American Medical Association","volume":" ","pages":""},"PeriodicalIF":55.0,"publicationDate":"2026-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149194874","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Word Origins. 词的起源。
IF 55
Journal of the American Medical Association Pub Date : 2026-10-15 DOI: 10.1001/jama.2025.16098
{"title":"Word Origins.","authors":"","doi":"10.1001/jama.2025.16098","DOIUrl":"https://doi.org/10.1001/jama.2025.16098","url":null,"abstract":"","PeriodicalId":17196,"journal":{"name":"Journal of the American Medical Association","volume":" ","pages":""},"PeriodicalIF":55.0,"publicationDate":"2026-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149194822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Engaging With Medical Evidence in the Age of AI. 人工智能时代的医学证据。
IF 55
Journal of the American Medical Association Pub Date : 2026-10-15 DOI: 10.1001/jama.2026.21894
Rohan Khera, Kirsten Bibbins-Domingo, Joseph S Ross
{"title":"Engaging With Medical Evidence in the Age of AI.","authors":"Rohan Khera, Kirsten Bibbins-Domingo, Joseph S Ross","doi":"10.1001/jama.2026.21894","DOIUrl":"https://doi.org/10.1001/jama.2026.21894","url":null,"abstract":"","PeriodicalId":17196,"journal":{"name":"Journal of the American Medical Association","volume":" ","pages":""},"PeriodicalIF":55.0,"publicationDate":"2026-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149194591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书